These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3167558)

  • 41. Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease.
    Schoemaker H; Pimoule C; Arbilla S; Scatton B; Javoy-Agid F; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):227-35. PubMed ID: 3927176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of a recombinant human dopamine transporter in multiple cell lines.
    Eshleman AJ; Neve RL; Janowsky A; Neve KA
    J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-correlated loss of dopamine uptake sites labeled with [3H]GBR-12935 in human putamen.
    Allard P; Marcusson JO
    Neurobiol Aging; 1989; 10(6):661-4. PubMed ID: 2628776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex.
    Janowsky A; Berger P; Vocci F; Labarca R; Skolnick P; Paul SM
    J Neurochem; 1986 Apr; 46(4):1272-6. PubMed ID: 3081686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropeptide-dopamine interactions. V. Cyclo(His-Pro) regulation of striatal dopamine transporter complex.
    Ikegami H; Prasad C
    Peptides; 1990; 11(1):145-8. PubMed ID: 2342989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cocaine accumulates in dopamine-rich regions of primate brain after i.v. administration: comparison with mazindol distribution.
    Madras BK; Kaufman MJ
    Synapse; 1994 Nov; 18(3):261-75. PubMed ID: 7855738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake on the dopamine uptake complex.
    Richfield EK
    Mol Pharmacol; 1993 Jan; 43(1):100-8. PubMed ID: 8423763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [3H]GBR 12935 binding in vivo in mouse brain: labelling of a piperazine acceptor site.
    Andersen PH; Jansen JA; Nielsen EB
    Eur J Pharmacol; 1987 Nov; 144(1):1-6. PubMed ID: 3436357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease.
    Allard P; Alafuzoff I; Carlsson A; Eriksson K; Ericson E; Gottfries CG; Marcusson JO
    Eur Neurol; 1990; 30(4):181-5. PubMed ID: 2209670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography.
    Donnan GA; Kaczmarczyk SJ; Paxinos G; Chilco PJ; Kalnins RM; Woodhouse DG; Mendelsohn FA
    J Comp Neurol; 1991 Feb; 304(3):419-34. PubMed ID: 2022757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of cocaine on dopamine transporter receptors depends on routes of chronic cocaine administration.
    Hitri A; Little KY; Ellinwood EH
    Neuropsychopharmacology; 1996 Mar; 14(3):205-10. PubMed ID: 8866704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO; Bäckström IT; Ross SB
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sodium independence of the binding of [3H]GBR 12783 and other dopamine uptake inhibitors to the dopamine uptake complex.
    Benmansour S; Bonnet JJ; Protais P; Costentin J
    Neurosci Lett; 1987 Jun; 77(1):97-102. PubMed ID: 3601221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines.
    Monsma FJ; Brassard DL; Sibley DR
    Brain Res; 1989 Jul; 492(1-2):314-24. PubMed ID: 2665904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [3H]WIN 35,065-2: a ligand for cocaine receptors in striatum.
    Ritz MC; Boja JW; Grigoriadis D; Zaczek R; Carroll FI; Lewis AH; Kuhar MJ
    J Neurochem; 1990 Nov; 55(5):1556-62. PubMed ID: 2120386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of dopamine transporter in bovine pineal gland using [3H]GBR 12935.
    Govitrapong P; Vilaipun P; Ebadi M
    J Pineal Res; 2003 Aug; 35(1):16-23. PubMed ID: 12823609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
    Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
    Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.